Galleon Pharmaceuticals, the first company to build a drug discovery and development platform focusing on pharmaceuticals for sleep apnea and related breathing-control disorders, has named Joseph Oliveto as chief executive officer, effective immediately. Mr. Oliveto replaces James Mannion, who will retire as chief executive officer and continue to serve as a strategic advisor to the company. Mr. Oliveto brings more than 25 years of pharmaceutical and biotech experience across the areas of dru...